A two-year-old girl struck by one of the worst cases of meningitis doctors had ever seen has defied the odds to see and smile again.
Kia Gott spent months in hospital with a rare strain of the deadly disease after being left stricken in September 2017.
Medics at the time believed that it had left her deaf, blind and brain damaged.
All of Kia's limbs were amputated at the Bradford Royal Infirmary after doctors confirmed she had the worst case of Meningitis C septicimia they had dealt with for 25 years.
Remarkably, Kia can now see.
Writing on her Facebook page back in March, Kia's family announced that their little girl can now see, although she needs glasses.
They uploaded a video a week ago of Kia smiling, despite being told that might never happen.
Writing on the Facebook page which documents Kia's recovery one of the parent's wrote, from Kia's point of view: "Hi every one, they said i would never smile, well here I am and smiling".
In September 2017 Kia's parents Paul and Vikki called 999. They had gone to check on her in the middle of the night and soon realised something was drastically wrong.
Dad Paul, 35, put the light on saw her face, neck and chest was covered in a terrible rash - a known symptom of meningococcal septicemia.
Paramedics arrived but her veins had collapsed, so they had to drill into her tiny shin to give her emergency drugs.
Kia was then rushed to Bradford Royal Infirmary where medics told her family it was meningitis and she was not likely to survive.
Specialists told the family it was the worst case of Meningitis C septicaemia they had dealt with for a quarter of a century.
Kia contracted the condition before she could receive the Men C vaccine, which is administered to infants at about 12 months old.
Meningitis can leave people with lasting problems, from epilepsy and deafness, to memory loss and blindness.
Septicaemia is what causes amputations, as well as kidney and lung damage.
The MenC vaccine is given to one-year-old babies in a single injection as a booster to their first Hib vaccines which are given at 8, 12 and 16-weeks-old.
The NHS says that it's extremely effective and products most children against the diseases, which is why rates of MenC are currently at their lowest ever in the UK.